Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
As of close of business last night, Ascendis Pharma A/S ADR’s stock clocked out at $139.50, down -0.11% from its previous closing price of $139.65. In other words, the price has decreased by -$0.11 from its previous closing price. On the day, 0.57 million shares were traded. ASND stock price reached its highest trading level at $142.09 during the session, while it also had its lowest trading level at $137.795.
Ratios:
To gain a deeper understanding of ASND’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.54 and its Current Ratio is at 0.83.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, TD Cowen on June 25, 2024, Upgraded its rating to Buy and sets its target price to $175 from $156 previously.
On May 31, 2024, Stifel started tracking the stock assigning a Buy rating and target price of $200.
On December 20, 2023, Jefferies started tracking the stock assigning a Buy rating and target price of $150.Jefferies initiated its Buy rating on December 20, 2023, with a $150 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ASND now has a Market Capitalization of 7970806784 and an Enterprise Value of 8356681728. For the stock, the TTM Price-to-Sale (P/S) ratio is 22.18. Its current Enterprise Value per Revenue stands at 25.398 whereas that against EBITDA is -23.572.
Stock Price History:
The Beta on a monthly basis for ASND is 0.62, which has changed by 0.54360557 over the last 52 weeks, in comparison to a change of 0.24841464 over the same period for the S&P500. Over the past 52 weeks, ASND has reached a high of $161.00, while it has fallen to a 52-week low of $85.29. The 50-Day Moving Average of the stock is 4.78%, while the 200-Day Moving Average is calculated to be 6.78%.
Shares Statistics:
It appears that ASND traded 373.53K shares on average per day over the past three months and 482980 shares per day over the past ten days. A total of 56.61M shares are outstanding, with a floating share count of 55.88M. Insiders hold about 1.30% of the company’s shares, while institutions hold 106.94% stake in the company. Shares short for ASND as of 1722384000 were 3504626 with a Short Ratio of 9.38, compared to 1719532800 on 3536354. Therefore, it implies a Short% of Shares Outstanding of 3504626 and a Short% of Float of 8.799999999999999.
